BELCHER PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at BELCHER PHARMACEUTICALS is $74,006, based on 118 certified filings from FY 2020 to FY 2026. This is 38% lower than the national H-1B median salary of $120,000. Compensation at BELCHER PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $61,173 and senior positions reaching $111,322 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at BELCHER PHARMACEUTICALS range from $55,058 at the 10th percentile to $111,322 at the 90th percentile, showing a $56,264 spread across experience levels and roles. The 25th percentile is $61,173 and the 75th percentile is $82,118.

Yes, BELCHER PHARMACEUTICALS actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), BELCHER PHARMACEUTICALS filed 10 H-1B labor condition applications with 10 certified and 0 denied, at a median salary of $83,574. Across FY 2020–2026, they have filed 121 total H-1B applications with 118 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. BELCHER PHARMACEUTICALS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), BELCHER PHARMACEUTICALS filed 10 H-1B applications, with 10 certified and 0 denied. Over 7 years of data, BELCHER PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

BELCHER PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 121 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating BELCHER PHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating BELCHER PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

BELCHER PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 118 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles BELCHER PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at BELCHER PHARMACEUTICALS:

The most frequently sponsored role is Sr. Chemist with 10 filings at a median salary of $74,256. This is followed by Research Scientist (8 filings) and Senior Chemist.

BELCHER PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where BELCHER PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top BELCHER PHARMACEUTICALS H-1B locations:

The largest H-1B hub for BELCHER PHARMACEUTICALS is Largo, FL with 118 filings at a median salary of $74,006.

BELCHER PHARMACEUTICALS's median H-1B salary has increased by +14% from FY 2020 ($73,000) to FY 2026 ($83,574). Tracking salary trends over time reveals how BELCHER PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at BELCHER PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2022: $80,184 (9 certified)
• FY 2023: $74,318 (14 certified)
• FY 2024: $76,170 (11 certified)
• FY 2025: $92,206 (20 certified)
• FY 2026: $83,574 (10 certified)

BELCHER PHARMACEUTICALS has maintained steady salary growth for H-1B positions over this period.

BELCHER PHARMACEUTICALS primarily files H-1B applications at Wage Level II, accounting for 36% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making BELCHER PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 93% of positions at Level II or higher, BELCHER PHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

BELCHER PHARMACEUTICALS's median H-1B salary of $74,006 is 38% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating BELCHER PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare BELCHER PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

BELCHER PHARMACEUTICALS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. BELCHER PHARMACEUTICALS's higher proportion of Level III-IV positions (57%) may benefit from wage-based lottery prioritization.

With 118 certified filings, BELCHER PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.